LON:BPCP

BioPharma Credit Share Forecast, Price & News

GBX 77.50

0.00 (0.00%)

(As of 07/1/2022 09:00 PM ET)

Add

Today's Range: 77.50
▼
77.50
50-Day Range: N/A
52-Week Range: 70.20
▼
81.82

Volume: 14,458 shs
Average Volume: N/A
Market Capitalization: £1.06 billion

P/E Ratio: 1,250.00
Dividend Yield: 7.34%
Price Target: N/A

BioPharma Credit MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.53 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BioPharma Credit.

0.0 Short Interest

Short Interest
There is no current short interest data available for BPCP.

1.7 Dividend Strength

Dividend Leadership
BioPharma Credit is a leading dividend payer. It pays a dividend yield of 7.34%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
BioPharma Credit does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of BioPharma Credit is 112.90%. Payout ratios above 75% are not desirable because they may not be sustainable.

0.0 Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BPCP.

1.1 News and Social Media Coverage

News Sentiment
BioPharma Credit has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of companies.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BioPharma Credit insiders have not sold or bought any company stock.

0.7 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of BioPharma Credit is 1,250.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 76.62.
Price to Book Value per Share Ratio
BioPharma Credit has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive BPCP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter.

About BioPharma Credit (LON:BPCP) Stock

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

June 19, 2022 | americanbankingnews.com

BioPharma Credit (LON:BPCP) Reaches New 1-Year Low at $79.00

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: LON:BPCP
CUSIP: N/A
CIK: N/A
Web: www.bpcruk.com
Phone: 44 13 9247 7500
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 1,250.00
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 16.51
Quick Ratio: 16.51

Sales & Book Value

Annual Sales: £103.88 million
Price / Sales: 10.25
Cash Flow: GBX 7.04 per share
Price / Cash Flow: 11.01
Book Value: GBX 99.30 per share
Price / Book: 0.78

Miscellaneous

Outstanding Shares: 1,373,932,000
Free Float: N/A
Market Cap: £1.06 billion
Optionable: Not Optionable
Beta: N/A

BioPharma Credit Frequently Asked Questions

How has BioPharma Credit's stock performed in 2022?: BioPharma Credit's stock was trading at GBX 80 on January 1st, 2022. Since then, BPCP stock has decreased by 3.1% and is now trading at GBX 77.50.
View the best growth stocks for 2022 here.
Is BioPharma Credit a good dividend stock?: BioPharma Credit(LON:BPCP) pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.34%. BPCP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of BioPharma Credit is 112.90%. Payout ratios above 75% are not desirable because they may not be sustainable.
Who are BioPharma Credit's key executives?: BioPharma Credit's management team includes the following people:
Mr. Pedro Gonzalez de Cosio, Investment Mang.
Mr. Pablo Gerardo Legorreta, Investment Mang. (Age 58)
Mr. Martin G. Friedman, Investment Mang. (Age 57)

What is BioPharma Credit's stock symbol?: BioPharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCP."
How do I buy shares of BioPharma Credit?: Shares of BPCP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is BioPharma Credit's stock price today?: One share of BPCP stock can currently be purchased for approximately GBX 77.50.
How much money does BioPharma Credit make?: BioPharma Credit (LON:BPCP) has a market capitalization of £1.06 billion and generates £103.88 million in revenue each year.
How can I contact BioPharma Credit?: The official website for BioPharma Credit is www.bpcruk.com. The company can be reached via phone at 44 13 9247 7500.

This page (LON:BPCP) was last updated on 7/4/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources